MedTrace Logo

Determining the Reproductive Health of Men Post-COVID-19 Infection

NCT04414904 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-11-24

No results posted yet for this study

Summary

Study rationale

1. An increasing proportion of the worldwide population is being infected with COVID-19.
2. There are ongoing and currently unanswered safety concerns about the effects of COVID-19 on reproductive health.
3. It will be immensely reassuring to rapidly report that COVID-19 has no detectable effects on male endocrine or sperm function. Conversely, if COVID-19 does impair male reproductive health, appropriate screening can be performed in couples trying to conceive, and further research can be undertaken.
4. The proposed study will be simple, rapid, and authoritative for the UK and worldwide.

Conditions

  • Infertility, Male
  • Testosterone Deficiency

Interventions

OTHER

Exposure: Covid-19 infection

Previous history of COVID-19 infection.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-10
Primary Completion
2020-06-10
Completion
2020-06-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04414904 on ClinicalTrials.gov